332793
Is Adopting Electronic Medical Records Associated with Increased Influenza Vaccination Rates in Nursing Homes?
Study Design:Employing merged MDS, CASPER, NHC and HIMSS datasets 2005-2011, a propensity score matching model with state-and-year fixed effects was developed. Five implications of HITs were assessed separately: a clinical data repository (CDR), clinical decision support systems (CDSS), order entry (OE), computerized provider order entry (CPOE), and physician documentation (PD). To cover the whole flu season, the MDS records from October through the following May were selected. Facility-level flu vaccination rates for long-stay and for short-stay residents were examined separately.
Principal Findings:From 2005-2011, the influenza vaccination rate for short-stay residents was 74.14% (SD = 19.24), and 86.57% (18.88) for long-stay. For short-stayers, flu shot rates were 3% higher (CI = [-0.73, 0.54]) for NHs adopting CDR, 1.20% higher (1.03, 2.01) for CDSS, 2.56% higher (1.87, 4.01) for OE, 7.73% higher (6.81, 8.01) for CPOE, and 10.11% (9.4, 10.41) for PD. For long-stayers, these rates were 0.5% higher (-1.27,1.01) for CDR, 0.51% higher (-0.76, 0.77) for CDSS, 1.77% higher (1.57, 2.01) for OE, 5.71% higher (4.88, 6.01) for CPOE, and 6.91% (5.99, 7.41) for PD.
Conclusions/Policy Implication: Adoption of CPOE and PD were associated with improved flu vaccination rates in NH residents. Hence, adopting HIT may be an effective way to improve NH care.
Learning Areas:
Public health or related nursingPublic health or related public policy
Public health or related research
Learning Objectives:
Analyze the relationship between EMR adoption and rate of influenza shot
Keyword(s): Aging
Qualified on the content I am responsible for because: I lead this project: designing the study, analyzing the data and writing the article.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.